title: Genomic amplification of the human telomerase RNA gene for differential diagnosis of cervical disorders.
abstract: To evaluate genomic amplification of the human telomerase RNA gene (TERC) as a supportive approach to cytopathology or histopathology in diagnosis of low-grade and high-grade uterine cervical lesions, 1,033 Chinese women at three medical centers had liquid-based thin-layer cytopathologic examination and TERC detection by fluorescence in situ hybridization (FISH). Human papillomavirus DNA testing, colposcopy with or without biopsy, and histopathologic examination were conducted as needed. In cytopathologic examination, genomic amplification of TERC was found in 30 of 659 (4.6%) normal or benign cellular changes; in 23 of 170 (13.5%) atypical squamous cells of undetermined significance (ASCUS); in 8 of 28 (28.6%) atypical squamous cells with high-grade squamous intraepithelial lesion possible (ASC-H); and in 26 of 103 (25.2%) low-grade (LSIL) and 64 of 73 (87.7%) high-grade (HSIL) squamous intraepithelial lesions; with pairwise significant difference (P< 0.05) in each, except ASC-H and LSIL (chi(2) = 0.127, P = 0.72). In histopathologic examination, TERC was amplified in 28 of 671 (4.2%) normal, inflammatory, or wart cases; in 17 of 233 (7.3%) cervical intraepithelial neoplasia grade 1 cases (CIN 1); in 27 of 39 (69.2%) CIN 2 cases; in 57 of 67 (85.1%) CIN 3 cases; and in 22 of 23 (95.7%) cervical cancer cases; with pairwise significant difference in each (P < 0.05). The number of cells with abnormal signals increased and the abnormal signal patterns were diversified with increasing severity of cervical dysplasia. FISH detection of TERC amplification may provide an effective, noninvasive approach in conjunction with cytopathologic or histopathologic evaluation for differential diagnosis of low- and high-grade cervical disorders.
authors.affiliation: Department of Gynecology, Peking University People's Hospital, No. 11 Xizhimen South Street, Beijing 100044, China.
authors.forename: Zheng
authors.initials: Z
authors.lastname: Tu
authors.forename: Aipeng
authors.initials: A
authors.lastname: Zhang
authors.forename: Ruifang
authors.initials: R
authors.lastname: Wu
authors.forename: Jing
authors.initials: J
authors.lastname: Jiang
authors.forename: Yali
authors.initials: Y
authors.lastname: Li
authors.forename: Na
authors.initials: N
authors.lastname: Wulan
authors.forename: Jingran
authors.initials: J
authors.lastname: Li
authors.forename: Yongmei
authors.initials: Y
authors.lastname: Zhang
authors.forename: Yibing
authors.initials: Y
authors.lastname: Li
authors.forename: Zhong
authors.initials: Z
authors.lastname: Chen
authors.forename: Lihui
authors.initials: L
authors.lastname: Wei
mesh_terms: D003937:Diagnosis, Differential; D005260:Female; D005784:Gene Amplification; D015894:Genome, Human / Q000235:genetics*; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D027383:Papillomaviridae / Q000235:genetics; D012313:RNA / Q000235:genetics*; D019098:Telomerase / Q000235:genetics*; D002577:Uterine Cervical Diseases / Q000175:diagnosis* / Q000201:enzymology / Q000235:genetics* / Q000473:pathology
chemical_list: C422952:telomerase RNA; D012313:RNA; D019098:Telomerase